{"uri": "eng-9433618", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Non-small-cell_lung_cancer", "type": "wiki", "score": 100, "label": {"eng": "Non-small-cell lung cancer"}}, {"uri": "http://en.wikipedia.org/wiki/Exon", "type": "wiki", "score": 100, "label": {"eng": "Exon"}}, {"uri": "http://en.wikipedia.org/wiki/China", "type": "loc", "score": 97, "label": {"eng": "China"}, "location": {"type": "country", "label": {"eng": "China"}}}, {"uri": "http://en.wikipedia.org/wiki/C-Met", "type": "wiki", "score": 68, "label": {"eng": "C-Met"}}, {"uri": "http://en.wikipedia.org/wiki/Metastasis", "type": "wiki", "score": 68, "label": {"eng": "Metastasis"}}, {"uri": "http://en.wikipedia.org/wiki/Cancer", "type": "wiki", "score": 66, "label": {"eng": "Cancer"}}, {"uri": "http://en.wikipedia.org/wiki/Confidence_interval", "type": "wiki", "score": 64, "label": {"eng": "Confidence interval"}}, {"uri": "http://en.wikipedia.org/wiki/Savolitinib", "type": "wiki", "score": 62, "label": {"eng": "Savolitinib"}}, {"uri": "http://en.wikipedia.org/wiki/Enzyme_inhibitor", "type": "wiki", "score": 58, "label": {"eng": "Enzyme inhibitor"}}, {"uri": "http://en.wikipedia.org/wiki/Neoplasm", "type": "wiki", "score": 57, "label": {"eng": "Neoplasm"}}, {"uri": "http://en.wikipedia.org/wiki/Lung_cancer", "type": "wiki", "score": 54, "label": {"eng": "Lung cancer"}}, {"uri": "http://en.wikipedia.org/wiki/AstraZeneca", "type": "org", "score": 54, "label": {"eng": "AstraZeneca"}}, {"uri": "http://en.wikipedia.org/wiki/Chemotherapy", "type": "wiki", "score": 54, "label": {"eng": "Chemotherapy"}}, {"uri": "http://en.wikipedia.org/wiki/Mutation", "type": "wiki", "score": 51, "label": {"eng": "Mutation"}}, {"uri": "http://en.wikipedia.org/wiki/Therapy", "type": "wiki", "score": 51, "label": {"eng": "Therapy"}}, {"uri": "http://en.wikipedia.org/wiki/Nasdaq", "type": "wiki", "score": 47, "label": {"eng": "Nasdaq"}}, {"uri": "http://en.wikipedia.org/wiki/Efficacy", "type": "wiki", "score": 47, "label": {"eng": "Efficacy"}}, {"uri": "http://en.wikipedia.org/wiki/United_States_Congress", "type": "wiki", "score": 45, "label": {"eng": "United States Congress"}}, {"uri": "http://en.wikipedia.org/wiki/Epithelium", "type": "wiki", "score": 43, "label": {"eng": "Epithelium"}}, {"uri": "http://en.wikipedia.org/wiki/Cohort_study", "type": "wiki", "score": 43, "label": {"eng": "Cohort study"}}, {"uri": "http://en.wikipedia.org/wiki/New_drug_application", "type": "wiki", "score": 41, "label": {"eng": "New drug application"}}, {"uri": "http://en.wikipedia.org/wiki/Median", "type": "wiki", "score": 34, "label": {"eng": "Median"}}, {"uri": "http://en.wikipedia.org/wiki/Shanghai", "type": "loc", "score": 33, "label": {"eng": "Shanghai"}, "location": {"type": "place", "label": {"eng": "Shanghai"}, "country": {"type": "country", "label": {"eng": "China"}}}}], "eventDate": "2024-03-28", "totalArticleCount": 7, "title": {"eng": "Hutchmed cancer treatment indication accepted for review in China"}, "summary": {"eng": "The AIM-traded firm said the application was targeting adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) featuring mesenchymal epithelial transition factor (MET) exon 14 skipping alteration.\n\nIf approved, the application would expand the label indication for savolitinib to include treatment-naive patients in China.\n\nSavolitinib, previously granted conditional approval in China for treating NSCLC patients with MET exon 14 skipping alterations who had progressed "}, "location": {"type": "place", "label": {"eng": "Shanghai"}, "country": {"type": "country", "label": {"eng": "China"}}}, "categories": [{"uri": "dmoz/Health/Conditions_and_Diseases/Cancer", "label": "dmoz/Health/Conditions and Diseases/Cancer", "wgt": 86}, {"uri": "dmoz/Health/Men's_Health/Conditions_and_Diseases", "label": "dmoz/Health/Men's Health/Conditions and Diseases", "wgt": 100}, {"uri": "dmoz/Health/Dentistry/Conditions_and_Diseases", "label": "dmoz/Health/Dentistry/Conditions and Diseases", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 93}], "articleCounts": {"eng": 7}, "sentiment": 0.2313725490196079, "wgt": 449280000, "relevance": 1}